Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Go back to Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results
(NASDAQ: VRDN) Delayed: 23.17 +0.25 (1.09%)
Previous Close $22.92    52 Week High
Open $22.38    52 Week Low
Day High $23.84    P/E N/A 
Day Low $22.22    EPS
Volume 1,829,318